Skip to content

Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie - Intu-trial

Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie - Intu-trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-001583-52-SE
Enrollment
Unknown
Registered
2004-08-13
Start date
2004-09-22
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory insufficiency in prematrue infants requiring ventilatory assistance and therefore intubation. Premedication before intubation.

Interventions

Trade Name: Ultiva® Pharmaceutical Form: Intravenous infusion INN or Proposed INN: remifentanil Concentration unit: mg/ml milligram(s)/millilitre Concentration number: 0.01 - Trade Name: Robinul Phar

Sponsors

Lund University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Gestational age less than 37 weeks at birth Group 1: = 72 h postnatal age not previously intubated not previously received analgetics or sedatives Group 2: > 72 h postnatal age first or repeated intubation 2. written parental informed consent Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Urgent intubation immediately post partum Asphyxia (Apgar <4 at 10 min age, U-pH <7.0) Major malformations Postsurgery intubaiton Other intervention study during the first week of life

Design outcomes

Primary

MeasureTime frame
Main Objective: To compare a balanced anestesia (BA), using the same medicines as in older age groups, with the routine premedication in use. To compare BA (including remifentanil) with morphine with regard to - Success in the intubation procedure - Analgesia during and after intubation - Stress reaction (physiological and biochemical parameters) ;Secondary Objective: 1. To compare pain scales and validate a scale (ALPS) for objective assessment of pain/distress during continuous neonatal intensive care. 2. To assess the individual pharmacogenetic profile in relation to the need of morphine after the intubation. ;Primary end point(s): Success of intubation according to - the Viby-Mogensen scale - assessment of duration of the procedure and changes in oxygen saturation and heart rate during the intubation.

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026